Fig. 3From: The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective studyProgression-free survival (A) and overall survival (B) of whole populations according to different PNI statusBack to article page